ARCHIVES

ODAC Member Critical Of Amgen For Price Incentives.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

Cuts Claimed to Displace “Millions” of Patients Yet None Seem to Complain. Why Not?

April 25, 2013

Computer Sciences Corp. Wins NIH Information System Contract

September 20, 2002

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

March 20, 2009

Amazon Links To NCI Materials, A First For NIH Health Content.

July 14, 2000

In Brief: Peck Joins GenPharm board; Dallas Hospital Selects director For New BMT Program

February 11, 1994

Also Bristol-Myers Squibb Under Federal Investigation Over Plavix Deal.

July 28, 2006